Related Experiment Video
Updated: May 28, 2025
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.8K
Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 (IGF2BP2) Promotes Castration-Resistant Prostate Cancer
Taruna Saini1, Devesh Srivastava1, Rajnikant Raut1
1Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Sangareddy, India.
Cancer Reports (Hoboken, N.J.)
|February 13, 2025
Summary
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) promotes castration-resistant prostate cancer (CRPC) by stabilizing androgen receptor variant 7 (AR-V7) mRNA. Targeting IGF2BP2 may offer a new therapeutic strategy for CRPC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Castration-resistant prostate cancer (CRPC) is challenging to treat due to the emergence of androgen receptor variant 7 (AR-V7).
- AR-V7 lacks the ligand-binding domain, rendering it resistant to standard androgen-deprivation therapies.
- The mechanisms regulating AR-V7 expression and function in CRPC are not fully understood.
Purpose of the Study:
- To investigate the role of IGF2BP2 in regulating AR-V7 expression and CRPC progression.
- To explore IGF2BP2 as a potential therapeutic target for CRPC.
Main Methods:
- Analysis of clinical mRNA expression data from CRPC patients.
- In vitro experiments involving IGF2BP2 knockdown and overexpression in CRPC cells.
- Assays included qRT-PCR, immunoblot, colony-formation, MTT, RIP-qPCR, and actinomycin-D treatment.
- Domain-deletion analysis of IGF2BP2 was performed.
Main Results:
- IGF2BP2 is upregulated in CRPC and correlates with higher Gleason scores.
- IGF2BP2 silencing downregulates AR-V7 and its targets, increasing sensitivity to enzalutamide.
- IGF2BP2 overexpression enhances AR-V7 expression and confers enzalutamide resistance.
- IGF2BP2 binds to the AR-V7 intronic splicing enhancer, stabilizing its mRNA.
Conclusions:
- IGF2BP2 is a key regulator of AR-V7 expression and stability in CRPC.
- IGF2BP2 represents a novel therapeutic target for CRPC treatment.
- Targeting IGF2BP2 could overcome resistance to enzalutamide in prostate cancer.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:15Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:23Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K